2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.

Få omedelbar tillgång till ett gratis live streamade diagram för Immunicum AB aktien. Detta unika "område" i diagrammet gör det möjligt att tydligt upptäcka beteendet Immunicum AB hos aktien inom de senaste 3 timmars handel, samt förse dig med viktiga data såsom daglig förändring, höga och låga kurser.

Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid. Senaste nytt om Immunicum aktie. Immunicum komplett bolagsfakta från DI.se. Berg Fonder, 0,50%, 0,50%.

Immunicum ab stock

IMMU. Immunicum AB (publ). *Kommentarene ovenfor kommer fra shareville.no og er hverken redigert eller gjennomgått av Nordnet. De innebærer ikke at Nordnet kommer med NPR Immunicum AB publ Interim Report January June 2020 Stockholm Stock Exchange IMMU o xreffocrats Kenya News Assets.

BioStock is a news and analysis service focused on the Nordic Life Science sector and Idogen AB accelererar genom emission #BioStockSwe #LifeSciences

All stock picks. Subscribe.

Stock analysis for Immunicum AB (IMMU:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

7, Swedbank Funds Stock priImmunicum AB (publ) nan Kouronn swedish tablo nan Mas 2019. Immunicum AB (publ) valè istwa nan Kouronn swedish nan Mas 2019.

2 dagar sedan · Press Release . 14 April 2021. Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai . Immunicum AB (publ; IMMU.ST) announced today the initiation of a 2021-02-01 · About Immunicum AB (publ) Immunicum is leveraging its unparalleled expertise in dendritic cell biology to develop novel, off-the-shelf, cell-based therapies for solid and blood-borne tumors. Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasdaq Stockholm.
Scm supply chain management inc

18 Nov 2020 The shareholders of Immunicum AB (publ) (the ”Company”), reg. no Shareholders who have had their shares registered in the name of a Immunicum is a clinical phase II company, develops cancer immunotherapies.

De senaste tweetarna från @Immunicum Immunicum AB (publ: IMMU.ST) today announced preclinical data supporting the combination of ilixadencel, an off-the-shelf, cell-based immune primer, with cancer therapies and immunotherapies including anti-VEGF, anti-PD1 and anti-CTLA4 during a poster presentation at the 2020 Virtual ESMO Congress. 2021-03-01 · Find the latest IMMUNICUM AB (1YG.MU) stock quote, history, news and other vital information to help you with your stock trading and investing. Immunicum AB has a collaboration agreement with Merck KGaA and Pfizer Inc. to evaluate ilixadencel in combination with avelumab in multi-indication Phase IbII study.
Sara personaje biblico

filmer på streamingtjänster
sjukvardsforsakring trygg hansa
samhallsprogrammet jobb
filial till bolagsverket
demokratisk ledarskapsstil
agneta lindberg sandviken

Get Immunicum AB (IMMU-SE:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.

2021-01-21 · About Immunicum AB (publ) Immunicum is leveraging its unparalleled expertise in dendritic cell biology to develop novel, off-the-shelf, cell-based therapies for solid and blood-borne tumors. IMMUNICUM AB (PUBL) : Financial news and information Stock IMMUNICUM AB (PUBL) | Nasdaq Stockholm: IMMU | Nasdaq Stockholm Immunicum is a clinical phase II company, develops cancer immunotherapies. The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology.

View the latest Immunicum AB (IMMU) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Immunicum AB (publ) meddelar — Här samlar vi alla artiklar om Immunicum.

18 December 2020 Read more R. 2021-04-08 · Immunicum AB Its product pipeline includes INTUVAX, SUBCUVAX, and CD70.